Modern Review,intestinal

The efficacy of bioactive peptides in delivering health benefits is intrinsically linked to their stability within the complex environment of the gastrointestinal tract. This journey, from ingestion to potential absorption, is fraught with challenges posed by the acidic conditions and enzymatic activity inherent to digestion. Understanding the factors influencing peptide stability is paramount for harnessing their full therapeutic and nutritional potential, particularly when considering oral delivery of biologics.

Bioactive peptides are short chains of amino acids derived from proteins, often possessing specific physiological functions. These can range from antihypertensive and antioxidant properties to immunomodulatory and antimicrobial effects. However, their inherent susceptibility to degradation by gastrointestinal proteases presents a significant hurdle. As noted in various studies, bioactive peptides can be stable or unstable to gastrointestinal proteases, with their gut stability being a critical determinant of their effectiveness.

The Gastrointestinal Gauntlet: Challenges to Peptide Integrity

Upon oral consumption, bioactive peptides first encounter the highly acidic environment of the stomach, primarily characterized by pepsin. This enzyme is a potent protease that can rapidly break down peptide bonds. Subsequently, in the small intestine, a cocktail of pancreatic and intestinal enzymes, including trypsin, chymotrypsin, carboxypeptidases, and aminopeptidases, further contributes to peptide hydrolysis. The effectiveness of these enzymes means that their inherent instability in the lumen of the gastrointestinal tract is a key bottleneck in oral peptide drug development.

The degree to which bioactive peptides survive this enzymatic onslaught dictates their bioavailability. Bioavailability of bioactive peptides (BAPs) represents the amount of peptides absorbed through normal pathways, after oral intake, and distributed in the body. For bioactive peptides to exert their intended effects, either locally within the digestive tract or systemically after absorption, they must resist extensive degradation. Research indicates that little unequivocal evidence exists that dietary bioactive peptides, other than di- and tripeptides, can cross the gut wall intact and enter circulation in significant quantities. This highlights the importance of strategies that enhance their resilience.

Factors Influencing Peptide Stability

The stability of bioactive peptides is not a uniform characteristic; it is influenced by a multitude of factors related to their intrinsic structure and the external environment of the gastrointestinal tract.

* Structural Properties: The role of structural properties of bioactive peptides in their stability is significant. Factors such as the amino acid sequence, the presence of disulfide bonds, and the overall three-dimensional conformation play a crucial role. For instance, cyclotides were identified as a class of scaffolds that could resist gastrointestinal degradation, even when modified. Disulfide-rich peptide scaffolds have also been investigated for their enhanced gut stability.

* Size and Charge: While smaller peptides, such as di- and tripeptides, are generally more readily absorbed, larger bioactive peptides face greater challenges. Their charge also influences their interaction with the intestinal epithelium and their susceptibility to enzymatic cleavage.

* Food Matrix: When consumed as part of a meal, the food matrix can significantly influence peptide stability. The presence of other proteins, carbohydrates, and fats can provide a protective effect or, conversely, compete for digestive enzymes. Studies considering food matrix and gastrointestinal effects in the bioaccessibility of bioactive peptides are crucial for understanding their real-world performance.

* Chemical Modifications: Various chemical strategies are employed to improve peptide stability. D-amino acid substitution is a common strategy to improve the stability of peptides. The introduction of D-amino acids can hinder the action of proteases, thereby increasing the peptide's resistance to degradation. Research in this area aims to develop orally administered peptide therapeutics with enhanced stability.

Strategies to Enhance Bioactive Peptide Stability and Bioavailability

Given the challenges, considerable research focuses on improving the stability of bioactive peptides for oral administration.

* Encapsulation and Delivery Systems: Encapsulation within various matrices, such as liposomes, nanoparticles, or hydrogels, can shield bioactive peptides from premature enzymatic degradation. Self-assembling bioactive peptides for gastrointestinal delivery are also being explored as innovative approaches.

* Chemical Modification: As mentioned, incorporating D-amino acids or other chemical modifications can enhance resistance to proteolysis.

* Enzymatic Hydrolysis Optimization: Understanding the enzymatic release of bioactive peptides from parent proteins is key. For example, the hydrolysis of orange seed proteins using pepsin to obtain bioactive peptides and study their stability is an area of investigation.

* Machine Learning Predictions: Advancements in technology are aiding this field. Machine learning predicts peptide stability in the gastrointestinal tract, offering a powerful tool for researchers to screen and design peptides with improved GI stability based solely on their amino acid sequence. This represents a significant step forward in advancing oral delivery of biologics.

The Broader Impact: Gut Microbiota and Health

Beyond direct absorption, bioactive peptides can also exert beneficial effects by modulating the gut microbiota and influencing gastrointestinal homeostasis. **Dietary bioactive